157 related articles for article (PubMed ID: 28856848)
21. Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
Murthy V; Masodkar R; Kalyani N; Mahantshetty U; Bakshi G; Prakash G; Joshi A; Prabhash K; Ghonge S; Shrivastava S
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):60-66. PubMed ID: 26547385
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
[TBL] [Abstract][Full Text] [Related]
23. Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.
Olsen JR; Moughan J; Myerson R; Abitbol A; Doncals DE; Johnson D; Schefter TE; Chen Y; Fisher B; Michalski J; Narayan S; Chang A; Crane CH; Kachnic L
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):400-408. PubMed ID: 28463160
[TBL] [Abstract][Full Text] [Related]
24. French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.
Vendrely V; Henriques de Figueiredo B; Rio E; Benech J; Belhomme S; Lisbona A; Frison E; Doussau A; Nomikossoff N; Mahé MA; Kantor G; Maire JP
Radiat Oncol; 2015 Aug; 10():170. PubMed ID: 26268888
[TBL] [Abstract][Full Text] [Related]
25. ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRT.
Damico N; Meyer J; Das P; Murphy J; Miller E; Koontz B; Hall W; McBride M; Pereira G; Catalano P; Chakravarthy AB; O'Dwyer PJ; Dorth J
Pract Radiat Oncol; 2022; 12(4):335-347. PubMed ID: 35717050
[TBL] [Abstract][Full Text] [Related]
26. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.
Engels B; Tournel K; Everaert H; Hoorens A; Sermeus A; Christian N; Storme G; Verellen D; De Ridder M
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):142-8. PubMed ID: 22014952
[TBL] [Abstract][Full Text] [Related]
28. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
[TBL] [Abstract][Full Text] [Related]
29. The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.
Franco P; Montagnani F; Arcadipane F; Casadei C; Andrikou K; Martini S; Iorio GC; Scartozzi M; Mistrangelo M; Fornaro L; Cassoni P; Cascinu S; Ricardi U; Casadei Gardini A
Radiat Oncol; 2018 May; 13(1):83. PubMed ID: 29720197
[TBL] [Abstract][Full Text] [Related]
30. A Dosimetric Analysis of Preoperative Intensity-modulated and Image-guided Radiation Therapy with and without Simultaneous Integrated Boost for Locally Advanced Rectal Cancer.
Yang Y; Feng L; Wang Y; Ge R; Gong H; Xie C; Wang J; Chen J; Lan Y; Ma L
Technol Cancer Res Treat; 2015 Oct; 14(5):557-63. PubMed ID: 24988052
[TBL] [Abstract][Full Text] [Related]
31. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
32. IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: plan evaluation and treatment outcome.
Kim JW; Cho JH; Keum KC; Kim JH; Kim GE; Lee JY; Kim SK; Lee CG
Jpn J Clin Oncol; 2012 Dec; 42(12):1152-60. PubMed ID: 23077243
[TBL] [Abstract][Full Text] [Related]
33. Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome.
Engels B; Platteaux N; Van den Begin R; Gevaert T; Sermeus A; Storme G; Verellen D; De Ridder M
Radiother Oncol; 2014 Jan; 110(1):155-9. PubMed ID: 24239243
[TBL] [Abstract][Full Text] [Related]
34. Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer.
Joseph K; Nijjar Y; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Ghosh S; Syme A; Nijjar T; Mulder K; Doll C; Wong C; Field C
Radiother Oncol; 2015 Nov; 117(2):234-9. PubMed ID: 26306677
[TBL] [Abstract][Full Text] [Related]
35. Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term results.
Gryc T; Ott O; Putz F; Knippen S; Raptis D; Fietkau R; Strnad V
Brachytherapy; 2016; 15(6):865-872. PubMed ID: 27720203
[TBL] [Abstract][Full Text] [Related]
36. Promising results with image guided intensity modulated radiotherapy for muscle invasive bladder cancer.
Whalley D; Caine H; McCloud P; Guo L; Kneebone A; Eade T
Radiat Oncol; 2015 Sep; 10():205. PubMed ID: 26407726
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study.
Xu Y; Zheng X; Bai X; Li P; Ma H; Wang J; Hu X; Chen M
Oncotarget; 2017 Jul; 8(30):49084-49092. PubMed ID: 28467775
[TBL] [Abstract][Full Text] [Related]
38. Image-guided Intensity-modulated Radiotherapy for Prostate Cancer Employing Hypofractionation and Simultaneous Integrated Boost: Results of a Consecutive Case Series with Focus on Erectile Function.
Girelli G; Franco P; Sciacero P; Cante D; Borca VC; Pasquino M; Annoscia S; Tofani S; La Porta MR; Ricardi U
Anticancer Res; 2015 Jul; 35(7):4177-82. PubMed ID: 26124375
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma.
Sakanaka K; Itasaka S; Ishida Y; Fujii K; Horimatsu T; Mizowaki T; Sakai Y; Hiraoka M
Radiat Oncol J; 2017 Dec; 35(4):368-379. PubMed ID: 28893059
[TBL] [Abstract][Full Text] [Related]
40. Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.
Macchia G; Cilla S; Deodato F; Legge F; Di Stefano A; Chiantera V; Scambia G; Valentini V; Morganti AG; Ferrandina G
Br J Radiol; 2015; 88(1055):20150385. PubMed ID: 26388108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
